Drug recall: These drugs recalled due to manufacturing issues

This article aims to shed light on the details of these recalls, the reasons behind them, and their potential impact on consumers.

Drug product Recall
Drug Recall

Last Updated on January 3, 2024 by The Health Master

Drug recall

Drug recall: In a recent development, the US Food and Drug Administration (USFDA) has reported recalls by prominent pharmaceutical companies such as Dr. Reddy’s Laboratories, Glenmark Pharma, and Zydus.

This article aims to shed light on the details of these recalls, the reasons behind them, and their potential impact on consumers.

Dr. Reddy’s Laboratories Recall:

Dr. Reddy’s Laboratories, based in Princeton, is recalling 1,656 bottles of Montelukast sodium tablets, a medication crucial for preventing asthma symptoms in adults.

The recall is attributed to the presence of foreign tablets and capsules, with a specific incident involving the misidentification of metoprolol 25 mg as Montelukast sodium tablets. The Class II voluntary recall was initiated on October 13, 2023.

Glenmark Pharma’s Recall:

Glenmark Pharmaceuticals Inc, USA, a unit of Mumbai-based Glenmark Pharma, is recalling 5,856 bottles of Deferasirox tablets for oral suspension, used to treat hemochromatosis.

Additionally, the company is recalling 16,944 bottles of Ranolazine Extended-Release tablets, employed in treating chronic chest pain.

Both recalls are due to failed dissolution specifications, with the Class II recall initiated on October 20 and October 23, 2023, respectively.

Zydus Pharmaceuticals Recall:

Zydus Pharmaceuticals (USA) Inc is recalling Oxybutynin Chloride extended-release tablets in various strengths due to failed dissolution specifications-out-of-specification test results.

he affected lot, manufactured by Cadila Healthcare Ltd, Baddi, Himachal Pradesh, led to the initiation of the Class II recall on October 19, 2023.

Class II Recall Definition:

A Class II recall, as defined by the USFDA, is initiated when the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences.

In situations where the probability of serious adverse health consequences is remote, a Class II recall is deemed appropriate.

Impact on Consumers:

Consumers of the affected medications face potential health risks due to the recalls. The presence of foreign substances or failed dissolution specifications raises concerns about the efficacy and safety of these pharmaceutical products.

Regulatory Procedures:

The USFDA is actively involved in addressing these recalls. The regulatory body ensures that appropriate measures are taken to safeguard public health, including the issuance of recalls and providing guidance to the companies involved.

Manufacturing Standards:

These recalls underscore the critical importance of maintaining high standards in pharmaceutical manufacturing. Straying from these standards can lead to mislabeled or ineffective medications, posing serious risks to patients.

Consumer Awareness:

It is crucial for consumers to stay informed about medication recalls. Being aware of the products being recalled and the reasons behind it empowers individuals to make informed decisions about their health.

Learning from Recalls:

The pharmaceutical industry must learn from such incidents. Conducting thorough quality control checks and implementing robust manufacturing processes are imperative to prevent similar recalls in the future.

Quality Assurance in Pharma:

Quality assurance plays a pivotal role in ensuring the safety and effectiveness of pharmaceutical products. Rigorous quality control measures must be in place to identify and rectify issues before products reach consumers.

Global Implications:

While these recalls are specific to the US market, they raise broader questions about global pharmaceutical standards. The interconnected nature of the pharmaceutical industry necessitates a global commitment to ensuring product safety.

Future Precautions:

To prevent future recalls, pharmaceutical companies should invest in advanced quality control technologies, adhere to stringent manufacturing guidelines, and foster a culture of continuous improvement in their processes.


  1. Q: How common are pharmaceutical recalls?
    • A: Pharmaceutical recalls are not uncommon but vary in frequency based on industry practices and regulatory oversight.
  2. Q: Can I continue taking my medication if it’s not part of a recall?
    • A: If your medication is not part of a recall, it is generally considered safe. However, consult your healthcare provider for personalized advice.
  3. Q: How does the USFDA determine the severity of a recall?
    • A: The USFDA categorizes recalls based on the potential health impact, with Class II recalls indicating a lower risk of serious adverse health consequences.
  4. Q: What steps can pharmaceutical companies take to prevent recalls?
    • A: Implementing robust quality control measures, adhering to manufacturing standards, and investing in advanced technologies can help prevent recalls.
  5. Q: How can consumers stay informed about medication recalls?
    • A: Consumers can regularly check the USFDA website, subscribe to recall alerts, and stay in touch with healthcare providers for updates.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
YouTube Icon